Home   >  
Angiogenesis/Protein Tyrosine Kinase

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Olmutinib dihydrochloride Chemical Structure
BCP38296 Olmutinib dihydrochloride 1842366-97-5
Olmutinib is an orally available, mutant-selective third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) that is being developed for treatment of advanced and metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC).
Orelabrutinib Chemical Structure
BCP37603 Orelabrutinib 1655504-04-3
Orelabrutinib is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor, being developed by InnoCare Pharma, for the treatment of chronic lymphocytic leukaemia.
Remibrutinib Chemical Structure
BCP36887 Remibrutinib 1787294-07-8
Remibrutinib, also known as LOU064, is a Bruton's tyrosine kinase inhibitor.
Btk inhibitor 1 R enantiomer hydrochloride Chemical Structure
BCP30305 Btk inhibitor 1 R enantiomer hydrochloride 1553977-42-6
Btk inhibitor 1R enantiomer Hcl is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.
QL47 Chemical Structure
BCP30763 QL47 1469988-75-7
QL47 is a potent, selective and irreversible BTK kinase inhibitor with IC50 of 7 nM.
BMX-IN-1 Chemical Structure
BCP30306 BMX-IN-1 1431525-23-3
BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.
PCI-29732 Chemical Structure
BCP30138 PCI-29732 330786-25-9
PCI-29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
(R)-Zanubrutinib Chemical Structure
BCP30082 (R)-Zanubrutinib 1691249-44-1
(R)-Zanubrutinib is the R enantiomer of Zanubrutinib. Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor.
Zanubrutinib Chemical Structure
BCP29110 Zanubrutinib 1691249-45-2
Zanubrutinib is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.
Vecabrutinib Chemical Structure
BCP29646 Vecabrutinib 1510829-06-7
Vecabrutinib, also known as SNS-062; FP-182, BSK-4841 and BIIB-062; is a potent, noncovalent, reversible BTK inhibitor that inhibits signaling through the BCR pathway.
123下一頁末頁共 34 條記錄 1 / 4 頁